Skip to main content

Table 4 Differences in the quality of life in migraineurs who use triptans and those using other drugs and/or no drugs

From: Long-term effects of a sensitisation campaign on migraine: the Casilino study

 

Follow-up

Triptans (n = 27)

No triptans (n = 135)

 

HIT-6

57.9 ± 11.9

57.4 ± 10.8

NS (p = 0.8377)

MIDAS III-IV

51.9%

57.0%

NS (p = 0.0617)